Prudential Financial’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,570
| Closed | -$24.1K | – | 2695 |
|
|
2022
Q4 | $24.1K | Sell |
1,570
-1,440
| -48% | -$16.8K | ﹤0.01% | 2557 |
|
|
2022
Q3 | $18K | Hold |
3,010
| – | – | ﹤0.01% | 2631 |
|
|
2022
Q2 | $28K | Buy |
+3,010
| New | +$53.5K | ﹤0.01% | 2630 |
|
|
2020
Q2 | – | Sell |
-674
| Closed | -$75K | – | 2485 |
|
|
2020
Q1 | $75K | Buy |
674
+68
| +11% | +$13.4K | ﹤0.01% | 2285 |
|
|
2019
Q4 | $148K | Sell |
606
-1,295
| -68% | -$327K | ﹤0.01% | 2353 |
|
|
2019
Q3 | $654K | Sell |
1,901
-5,352
| -74% | -$2.91M | ﹤0.01% | 1974 |
|
|
2019
Q2 | $6.67M | Sell |
7,253
-977
| -12% | -$1.2M | 0.01% | 1016 |
|
|
2019
Q1 | $13.1M | Buy |
8,230
+3,362
| +69% | +$6.06M | 0.02% | 719 |
|
|
2018
Q4 | $9.1M | Buy |
4,868
+1,175
| +32% | +$2.56M | 0.02% | 848 |
|
|
2018
Q3 | $8.71M | Buy |
3,693
+1,349
| +58% | +$4.18M | 0.01% | 966 |
|
|
2018
Q2 | $8.07M | Sell |
2,344
-231
| -9% | -$707K | 0.01% | 1022 |
|
|
2018
Q1 | $7.31M | Buy |
2,575
+572
| +29% | +$1.71M | 0.01% | 1034 |
|
|
2017
Q4 | $5.16M | Buy |
2,003
+650
| +48% | +$1.85M | 0.01% | 1137 |
|
|
2017
Q3 | $3.84M | Sell |
1,353
-139
| -9% | -$366K | 0.01% | 1262 |
|
|
2017
Q2 | $3.53M | Sell |
1,492
-706
| -32% | -$1.4M | 0.01% | 1286 |
|
|
2017
Q1 | $5.54M | Buy |
2,198
+1,234
| +128% | +$3.55M | 0.01% | 1085 |
|
|
2016
Q4 | $2.17M | Buy |
964
+159
| +20% | +$378K | ﹤0.01% | 1504 |
|
|
2016
Q3 | $2.02M | Sell |
805
-2,806
| -78% | -$8.37M | ﹤0.01% | 1514 |
|
|
2016
Q2 | $11.1M | Buy |
3,611
+781
| +28% | +$2.54M | 0.02% | 781 |
|
|
2016
Q1 | $8.98M | Buy |
2,830
+1,995
| +239% | +$8.28M | 0.02% | 855 |
|
|
2015
Q4 | $4.29M | Buy |
835
+15
| +2% | +$65.6K | 0.01% | 1134 |
|
|
2015
Q3 | $2.61M | Buy |
820
+10
| +1% | +$38.8K | 0.01% | 1339 |
|
|
2015
Q2 | $3.24M | Sell |
810
-428
| -35% | -$1.65M | 0.01% | 1318 |
|
|
2015
Q1 | $4.94M | Sell |
1,238
-66
| -5% | -$302K | 0.01% | 1144 |
|
|
2014
Q4 | $6.39M | Sell |
1,304
-39
| -3% | -$167K | 0.01% | 885 |
|
|
2014
Q3 | $5.46M | Sell |
1,343
-810
| -38% | -$3.04M | 0.01% | 917 |
|
|
2014
Q2 | $8.71M | Sell |
2,153
-33
| -2% | -$135K | 0.02% | 764 |
|
|
2014
Q1 | $9.95M | Sell |
2,186
-21
| -1% | -$84.9K | 0.02% | 714 |
|
|
2013
Q4 | $7.73M | Buy |
2,207
+18
| +0.8% | +$70.2K | 0.02% | 790 |
|
|
2013
Q3 | $9M | Buy |
2,189
+439
| +25% | +$1.89M | 0.02% | 702 |
|
|
2013
Q2 | $6.93M | Buy |
+1,750
| New | +$7.21M | 0.02% | 762 |
|
Other funds holding ACOR
DKCM
DKP
TSS
BCM
Prudential Financial's ACOR Position: Q1 2023 in Review
Prudential Financial sold out of Acorda Therapeutics (ACOR) in Q1 2023, closing a stake of 1,570 shares — an estimated $24.1K sold.
Prudential Financial first reported a position in ACOR in Q2 2013 and held it in 31 quarters. The position peaked at $13.1M in Q1 2019. 29 funds tracked by Wall St. Rank hold ACOR as of Q1 2023.
- Prudential Financial reported no remaining Acorda Therapeutics position as of Q1 2023 after selling out during the quarter.
- Prudential Financial sold 1,570 Acorda Therapeutics shares in Q1 2023, an estimated $24.1K.
- Prudential Financial first reported a position in Acorda Therapeutics in Q2 2013 and held it in 31 quarters.
- Prudential Financial's Acorda Therapeutics position peaked at $13.1M in Q1 2019.
- 29 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2023.
Based on Prudential Financial's 13F filing for Q1 2023, filed 12 May 2023.